|
Delayed
Bombay S.E.
04:54:30 20/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 4,997.85 INR | -0.30% |
|
+2.54% | +30.15% |
| 31/07 | Torrent Pharmaceuticals Limited, Q1 2027 Earnings Call, Jul 30, 2026 | |
| 30/07 | Torrent Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,907B 19.95B 17.11B 15.98B 14.66B 27.57B 28.02B 189B 73.83B 956B 74.91B 73.28B 3,162B | P/E 2027 * |
74.5x | P/E 2028 * | 53.9x |
|---|---|---|---|---|---|
| Enterprise Value | 2,029B 21.23B 18.21B 17B 15.6B 29.33B 29.82B 201B 78.56B 1,018B 79.7B 77.96B 3,364B | EV / Sales 2027 * |
10.2x | EV / Sales 2028 * | 8.98x |
| Free-Float |
36.58% | Yield 2027 * |
0.65% | Yield 2028 * | 0.76% |
Last Transcript: Torrent Pharmaceuticals Limited
| 1 day | -0.26% | ||
| 1 week | +2.54% | ||
| Current month | -2.01% | ||
| 1 month | -0.06% | ||
| 3 months | +12.87% | ||
| 6 months | +17.99% | ||
| Current year | +30.15% |
| 1 week | 4,806 |  | 5,045 |
| 1 month | 4,806 | | 5,249.95 |
| Current year | 3,724.1 | | 5,249.95 |
| 1 year | 3,480 | | 5,249.95 |
| 3 years | 1,771.35 | | 5,249.95 |
| 5 years | 1,242.5 | | 5,249.95 |
| 10 years | 571.75 | | 5,249.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aman Samir Mehta
CEO | Chief Executive Officer | 34 | 01/08/2025 |
Sudhir Menon
DFI | Director of Finance/CFO | - | 01/09/2018 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 62 | 30/07/2014 | |
Nayantara Bali
BRD | Director/Board Member | 59 | 07/03/2019 |
| Director/Board Member | 58 | 29/07/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/11/24 | Buy | Chief Operating Officer | 930,144 | 0.2748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.30% | +2.54% | +36.50% | +152.75% | 19.95B | |
| +4.46% | +4.92% | +82.07% | +134.31% | 1,141B | |
| +0.85% | +4.81% | +53.77% | +58.51% | 659B | |
| +2.72% | +6.92% | +28.99% | +77.15% | 470B | |
| +1.80% | +0.52% | +41.20% | +44.05% | 366B | |
| +1.24% | +2.35% | +25.99% | +42.21% | 302B | |
| +2.07% | +2.97% | +2.27% | +13.06% | 254B | |
| +4.02% | +6.29% | +49.67% | +68.96% | 239B | |
| +1.05% | -0.02% | -13.96% | -52.13% | 207B | |
| +2.90% | +8.63% | +25.11% | +94.52% | 183B | |
| Average | +1.70% | +3.95% | +33.16% | +63.34% | 384.09B | |
| Weighted average by Cap. | +1.52% | +4.30% | +47.00% | +74.55% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 198B 2.07B 1.78B 1.66B 1.52B 2.86B 2.91B 19.59B 7.67B 99.33B 7.78B 7.61B 328B | 223B 2.33B 2B 1.87B 1.71B 3.22B 3.27B 22.03B 8.63B 112B 8.75B 8.56B 369B |
| Net income | 24.72B 259M 222M 207M 190M 357M 363M 2.44B 957M 12.4B 971M 950M 41B | 34.25B 358M 307M 287M 263M 495M 503M 3.39B 1.33B 17.18B 1.35B 1.32B 56.8B |
| Net Debt | 122B 1.28B 1.09B 1.02B 938M 1.76B 1.79B 12.06B 4.72B 61.19B 4.79B 4.69B 202B | 93.6B 979M 840M 784M 720M 1.35B 1.38B 9.26B 3.62B 46.94B 3.68B 3.6B 155B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | INR 4,997.85 | -0.30% | 4,899 |
| 19/08/26 | INR 5,013.00 | +0.76% | 88,307 |
| 18/08/26 | INR 4,975.00 | +1.63% | 14,690 |
| 17/08/26 | INR 4,895.00 | +1.13% | 14,915 |
| 14/08/26 | INR 4,840.30 | -0.74% | 3,907 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TORNTPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
